New Delhi: Russian Sputnik vaccine is effective against all the new variants of the COVID-19, the Gamaleya institute has said. It is developing the vaccine against Covid-19, along with Russia’s sovereign wealth fund, Russian Direct Investment Fund (RDIF).
The Gamaleya institute said that during a study conducted by it, vaccination with Sputnik V has produced protective neutralising titers against new variants, including Alpha (B.1.1.7) – first identified in UK – Beta (B.1.351) – first identified in South Africa – Gamma (P.1) – first identified in Brazil – and Delta (B.1.617.2 and B.1.617.3), first identified in India.
The coronavirus vaccine is also able top provide protection against Moscow endemic variants B.1.1.141 and B.1.1.317.
The vaccine is a two-dose shot (but two unidentical doses unlike other two-dose vaccines) that is 91.6% effective in preventing serious illness as was found in phase 3 clinical trials.ute further said.